Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-04-10
1978-12-19
Schwartz, Gerald A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424280, 424316, 424321, 424324, A61K 31155
Patent
active
041306635
ABSTRACT:
Styrylamidines are prepared by treating styrylsulfonylamidines with base. The styrylamidines are effective in the prevention of aggregation of blood platelets and as analgesics. Compounds of the invention are also useful as anticonvulsants, diuretics, and antihypertensive agents. The styrylsulfonylamidines of the invention which serve as precursors to the styrylamidines also have analgesic properties. Illustrative of the styrylamidines of the present invention are 4-amino-N-(4-aminostyryl)benzamidine and N-(3,4-dichlorostyryl)acetamidine. An example of a styrylsulfonylamidine is N-(styrylsulfonyl)acetamidine.
REFERENCES:
patent: 3413345 (1968-11-01), Mull
Matier et al., "Formation of 5-aryl-1,2,4-thiadiazine-1,1-dioxides and Strylamidines from Strylsulfonylamidines," 4th Int'n Congress of Heterocyclic Chemistry, Salt Lake City, Utah (Jul. 1973).
Madison & Boyd, "Organic Chemistry," pp. 111-112, 526-534 (1962).
Comer William T.
Matier William L.
Carnaham Robert E.
Mead Johnson & Company
Schwartz Gerald A.
Uloth Robert H.
LandOfFree
Styrylamidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Styrylamidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styrylamidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2373867